retigabine EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedN03AX21
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012485
Compound index — R
534 substances begin with R. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, retigabine – Rosa centifolia.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Retinol CA-NHPUS-DRUG Not yet graded
Revefenacin US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnticholinergic [EPC]; Cholinergic Antagonists [MoA]
Earliest US approval2018
Market presence7 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012487
Revumenib Citrate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedMenin Inhibitor [EPC]; Menin Inhibitors [MoA]
Earliest US approval2024
Market presence5 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012488
Reynoutria japonica CA-NHP Not yet graded
CA licensed ingredient
Market presence324 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012489
Reynoutria japonica extract CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012490
Reynoutria Japonica Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012491
Reynoutria Japonica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012492
Reynoutria multiflora CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Chinese knotweed; Tuber fleeceflower; Chinese fleeceflower; Polygonum multiflorum Thunb.; Fallopia multiflora (Thunb.) K. Haraldson
Market presence507 Canadian licensed products
Parts in scopeRoots (rhizome), stem, bark and seeds
Etalyn identifierETA-C-012493
Reynoutria Multiflora Root US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012494
Rezafungin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedEchinocandin Antifungal [EPC]; J02AX08; Lipopeptides [CS]
Earliest US approval2023
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012495
RH-Oligopeptide-1 US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012496
Rhamni purshianae cortex EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Cascara; Rhamnus purshianusD.C.
Class as recordedherbal: Constipation
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-012497
Rhamnogalacturonan-rich pectin hydrolysate EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012498
Rhamnus californica CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012499
Rhamnus cathartica CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012500
Rhamnus Cathartica Bark US-DRUG Not yet graded
US: unapproved drug other
Class as recordedVitamin D [CS]; Vitamin D [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012501
Rhamnus Cathartica Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012502
Rhamnus frangula CA-NHP Not yet graded
CA licensed ingredient
Market presence31 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012503
Rhamnus purshiana CA-NHP Not yet graded
CA licensed ingredient
Market presence39 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012504
Rhamnus Purshianus CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012505
Rhamphospermum Arvense Flowering/fruiting TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012506
Rhaponticum carthamoides CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012507
Rhaponticum uniflorum CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012508
Rhei radix EU-HERBUS-DRUG Not yet graded
Herbal monograph: F: Assessment finalisedUS: unapproved drug other
also: Rhubarb; Rheum palmatumL.;Rheum officinale Baillon
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence5 US product listings
Etalyn identifierETA-C-012509
Rhenium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calcium [CS]; Calcium [EPC]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012510
Rheum CA-NHP Not yet graded
CA licensed ingredient
Market presence32 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012511
Rheum officinale CA-NHP Not yet graded
CA licensed ingredient
Market presence683 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012512
Rheum Officinale Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence20 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012513
Rheum Officinale Stem US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012514
Rheum palmatum CA-NHP Not yet graded
CA licensed ingredient
Market presence361 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012515
Rheum Palmatum Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Calculi Dissolution Agent [EPC]
Market presence15 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012516
Rheum pumilum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012517
Rheum rhabarbarum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012518
Rheum rhabarbarum L. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeStem; Root and rhizome; Leaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012519
Rheum rhaponticum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012520
Rheum tanguticum CA-NHP Not yet graded
CA licensed ingredient
Market presence75 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012521
Rheum Tanguticum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012522
Rheum undulatum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012523
Rhizoma Alismatis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012524
Rhizoma Anemarrhenae CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012525
Rhizoma Arisaematis Preparata CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012526
Rhizoma Atractylodis Macrocephalae CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012527
Rhizoma cyperi CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012528
Rhizoma Dioscoreae Spongiosae CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012529
Rhizoma menispermi CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012530
Rhizoma zingiberis recens CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012531
Rhizopus Arrhizus CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: bla
also: Rhizopus oryzae
Class as recordedAllergens [CS]; Allergens [Chemical/Ingredient]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]
Market presence10 US product listings · 4 Canadian licensed products
Parts in scopeWhole
Etalyn identifierETA-C-012532
Rhizopus Stolonifer US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence60 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012533
Rhodiola CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012534
Rhodiola crenulata CA-NHP Not yet graded
CA licensed ingredient
Market presence93 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012535
Rhodiola Kirilowii Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012536
Rhodiola rosea CA-NHPETALYNEU-NOVEL D/insufficientband 6
Rhodiola rosea extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012538
Rhodiola rosea L. CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012539
Rhodiola rosea L. extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to reduce tiredness in case of stress” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005602
Rhodiolae roseae rhizoma et radix EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Arctic root; Rhodiola roseaL.
Class as recordedherbal: Fatigue and weakness;Mental stress and mood disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-012540
Rhodium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence17 US product listings · 1 Canadian licensed products
Etalyn identifierETA-C-012541
Rhodium metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012542
Rhodocactus Grandifolius Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012543
Rhododendron CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012544
Rhododendron aureum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012545
Rhododendron Aureum Leaf US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence50 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012546
Rhododendron Aureum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012547
Rhododendron campylocarpum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012548
Rhododendron Campylocarpum Whole US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012549
Rhododendron caucasicum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012550
Rhododendron Caucasicum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012551
Rhododendron chrysanthum CA-NHP Not yet graded
CA licensed ingredient
Market presence28 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012552
Rhododendron dauricum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012553
Rhododendron ferrugineum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012554
Rhododendron Ferrugineum Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012555
Rhododendron Ferrugineum Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012556
Rhododendron groenlandicum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012557
Rhododendron Tomentosum Leafy Twig US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence142 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012558
Rhodomyrtus tomentosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012559
Rhodonite CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012560
Rhodotorula Mucilaginosa US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012561
Rhodotorula Rubra US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antidote [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012562
Rhodymenia palmata CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012563
Rhopalurus Junceus Venom US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012564
Rhopalurus Princeps Venom US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012565
Rhus aromatica CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012566
Rhus Aromatica Root Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012567
Rhus chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012568
Rhus coriaria CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012569
Rhus glabra CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012570
Rhus Glabra TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012571
Rhus toxicodendron CA-NHP Not yet graded
CA licensed ingredient
Market presence257 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012572
Rhus Typhina Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012573
Rhus venenata CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012574
Ribavirin EU-MEDUS-DRUG Not yet graded
EU medicine: Lapsed, WithdrawnUS: anda
Class as recordedJ05AB04; J05AP01; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
Earliest US approval1985
Market presence20 US product listings · 17 FDA applications · 6 EU medicines
Etalyn identifierETA-C-012575
Ribes nigrum CA-NHP Not yet graded
CA licensed ingredient
Market presence374 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012576
Ribes Nigrum Flower BUD US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012577
Ribes nigrum L. (Common name: Blackcurrant) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Soothing for mouth and throat / Reliefs in case of tickle in the throat and pharynx / Soothing and pleasant effect on throat, pharynx and vocal cords.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005603
Ribes Nigrum Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antigens; Cell-mediated Immunity [PE]; Dermatophagoides [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012578
Ribes rubrum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012579
Ribis nigri folium EU-HERB Not yet graded
Herbal monograph: P: Draft published
also: Ribes nigrumL.; Blackcurrant Leaf
Class as recordedherbal: Pain and inflammation;Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-012580
Ribo-2,3,4,5-tetrahydroxyvaleraldehyde, D- CA-NHP Not yet graded
CA licensed ingredient
Market presence198 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012581
Ribociclib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; L01EF02
Earliest US approval2017
Market presence11 US product listings · 4 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012582
Riboflavin CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 9 authorised / 0 refusedCA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Earliest US approval1953
Market presence152 US product listings · 5 FDA applications · 9,063 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Riboflavin contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the maintenance of normal mucous membranes” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the maintenance of normal red blood cells” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the maintenance of normal skin” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the maintenance of normal vision” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the normal metabolism of iron” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the protection of cells from oxidative stress” | Authorised | Art.13(1) | EFSA opinion |
| “Riboflavin contributes to the reduction of tiredness and fatigue” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-012583
Riboflavin 5'-Phosphate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Increased Prothrombin Activity [PE]; Photoabsorption [MoA]
Earliest US approval1947
Market presence19 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012584
Riboflavinum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012585
Ribonucleic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012586
Ribonucleotides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012587
Ribose CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in supplementsEU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence8 Canadian licensed products
Parts in scopeSubstance
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “ATP is used for energy by muscle cells. Ribose helps regenerate muscle ATP levels, thereby improving exercise performance and recovery” “Ribose helps maintain cellular energy” “Ribose enhances recovery after strenuous activity” “Ribose is an important building block for cellular energy”” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-012588
Ribose, D- US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012589
Rice CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012591
Rice Germ US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012592
Rice Protein CA-NHP Not yet graded
CA licensed ingredient
Market presence506 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012593
Rice protein concentrate CA-NHP Not yet graded
CA licensed ingredient
Market presence209 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012594
Rice starch CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012595
Rice vinegar extract - INRV-08 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to balance the acidity of the body Helps to promote the acide-base balance of the body Helps to the detoxification of the body Used to facilitate the weight loss Helps to loose weight Contributes to loose weight Used to facilitate the weight loss Helps in weight control Contributes to body weight management” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012596
Rich in dietary fibre EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “A nutritionally balanced diet high in dietary fibre is important for maintaining bowel regularity.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Diets high in fibre help control your weight.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012597
rich in trytophane EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “help to reduce carbohydrate addiction. help to prevent carbohydrate consumption” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-012598
Ricini oleum CA-NHPEU-HERBUS-DRUG Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredientUS: otc monograph drug
also: Castor Oil; Ricinus communisL.
Class as recordedherbal: Gastrointestinal disorders
Market presence29 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-012600
Ricinus communis CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012601
Ricinus Communis (castor) Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012603
Ricinus Communis Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bismuth [CS]; Bismuth [EPC]; Blood Coagulation Factor [EPC]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012602
Rickettsia Akari US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012604
Rickettsia Prowazekii US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012605
Rickettsia Rickettsii US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012606
Rickettsia Typhi US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012607
Rifabutin US-DRUG Not yet graded
US: anda
Class as recordedCytochrome P450 2C19 Inhibitors [MoA]; Penicillin-class Antibacterial [EPC]; Penicillins [CS]; Proton Pump Inhibitor [EPC]
Earliest US approval1992
Market presence9 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012608
Rifampin US-DRUG Not yet graded
US: anda
Class as recordedRifamycin Antibacterial [EPC]; Rifamycins [CS]
Earliest US approval1971
Market presence31 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012609
Rifamycin O US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012611
Rifamycin Sodium US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2018
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012610
Rifapentine US-DRUG Not yet graded
US: anda
Class as recordedRifamycin Antimycobacterial [EPC]; Rifamycins [CS]
Earliest US approval1998
Market presence4 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012612
Rifaximin US-DRUG Not yet graded
US: bulk ingredient
Class as recordedRifamycin Antibacterial [EPC]; Rifamycins [CS]
Earliest US approval2004
Market presence24 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012613
Rilonacept EU-MEDUS-DRUG Not yet graded
Rilpivirine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedHIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
Earliest US approval2011
Market presence30 US product listings · 14 FDA applications · 5 EU medicines
Etalyn identifierETA-C-012615
Riluzole EU-MEDUS-DRUG Not yet graded
Rimabotulinumtoxinb US-DRUG Not yet graded
US: bla
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012618
Rimantadine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedInfluenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]
Earliest US approval1993
Market presence2 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012619
Rimegepant EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCalcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]; N02CD06
Earliest US approval2020
Market presence16 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012620
Rimexolone US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1994
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012621
rimonabant EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedA08AX01
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012622
Rinfabate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Increased Uterine Smooth Muscle Contraction or Tone [PE]; Oxytocic [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012623
Riociguat EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, OpinionUS: anda
Class as recordedC02KX05; Guanylate Cyclase Stimulators [MoA]; Soluble Guanylate Cyclase Stimulator [EPC]
Earliest US approval2013
Market presence22 US product listings · 3 FDA applications · 2 EU medicines
Etalyn identifierETA-C-012624
Ripretinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Kinase Inhibitor [EPC]; L01
Earliest US approval2020
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012625
Risankizumab-Rzaa US-DRUG Not yet graded
Earliest US approval2019
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012627
Risdiplam EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedIncreased Protein Synthesis [PE]; M09AX10; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
Earliest US approval2020
Market presence3 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012628
Risedronate Sodium US-DRUG Not yet graded
US: anda
Class as recordedBisphosphonate [EPC]; Diphosphonates [CS]
Earliest US approval1998
Market presence35 US product listings · 17 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012629
Risedronate Sodium Hemi-Pentahydrate US-DRUG Not yet graded
US: anda
Class as recordedBisphosphonate [EPC]; Diphosphonates [CS]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012630
Risedronate Sodium Hemipentahydrate US-DRUG Not yet graded
US: nda
Class as recordedBisphosphonate [EPC]; Diphosphonates [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012631
Risperidone EU-MEDUS-DRUG Not yet graded
ritlecitinib tosilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL04AF08
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012634
Ritlecitinib Tosylate US-DRUG Not yet graded
US: drug for further processing
Class as recordedCytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Janus Kinase 3 Inhibitors [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012633
Ritodrine Hydrochloride US-DRUG Not yet graded
Earliest US approval1980
Market presence9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012635
Ritonavir EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]
Earliest US approval1996
Market presence39 US product listings · 34 FDA applications · 6 EU medicines
Etalyn identifierETA-C-012636
Rituximab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedCD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]; Endoglycosidase [EPC]; Glycoside Hydrolases [CS]
Earliest US approval1997
Market presence21 US product listings · 2 FDA applications · 10 EU medicines
Etalyn identifierETA-C-012637
Rituximab-Abbs US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012638
Rituximab-Arrx US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012639
Rituximab-Pvvr US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2019
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012640
Rivaroxaban EU-MEDUS-DRUG Not yet graded
Rivastigmine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]; N06DA03
Earliest US approval2000
Market presence97 US product listings · 20 FDA applications · 8 EU medicines
Etalyn identifierETA-C-012642
rivastigmine hydrogen tartrate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedN06DA03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-012643
Rizatriptan Benzoate US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval1998
Market presence90 US product listings · 29 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012644
RNA CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012645
RNA-100-AR02 US-DRUG Not yet graded
US: bla
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012646
RNA-Binding Protein 10 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012647
Roasted sponge CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012648
Robenidine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012650
Robina pseudacacia CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012651
Robinia pseudoacacia CA-NHP Not yet graded
CA licensed ingredient
Market presence34 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012652
Robinia Pseudoacacia Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Bismuth [CS]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012653
Robinia Pseudoacacia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012654
Robinia Pseudoacacia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012655
Rock water CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012656
Rocuronium Bromide US-DRUG Not yet graded
US: anda
Class as recordedNeuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
Earliest US approval1994
Market presence76 US product listings · 24 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012657
Rofecoxib US-DRUG Not yet graded
Earliest US approval1999
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012658
Roflumilast EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedPhosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]; R03DX07; R03DX08
Earliest US approval2011
Market presence52 US product listings · 14 FDA applications · 3 EU medicines
Etalyn identifierETA-C-012659
Rolapitant EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bulk ingredient
Class as recordedA04AD; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]
Earliest US approval2015
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012660
Roluperidone Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012661
Romidepsin EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: anda
Class as recordedBile Salt Export Pump Inhibitors [MoA]; Histone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]; L01XX39
Earliest US approval2009
Market presence4 US product listings · 4 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012662
Romifidine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012663
Romiplostim EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedB02BX04; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Thrombopoietin Receptor Agonist [EPC]
Earliest US approval2008
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-012664
Romosozumab-Aqqg US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012666
Ronidazole US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012667
Rooster comb extract EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeRooster comb extract; Rooster comb extract
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-012668
Ropeginterferon Alfa-2B-Njft US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012670
Ropinirole EU-MEDUS-DRUG Not yet graded
Ropivacaine US-DRUG Not yet graded
US: anda
Class as recordedAmide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]
Earliest US approval1996
Market presence99 US product listings · 17 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012672
Ropocamptide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012673
Rorippa nasturtium-aquaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012674
Rorippia nasturtium-aquatica CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: drug for further processing
also: Water cress; Nasturtium Officinale; Arabis nasturtium [Clairv.] , Rorippia nasturtium-aquaticum (L.) Hayek
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence42 US product listings · 179 Canadian licensed products
Parts in scopeAerial parts; Whole
Etalyn identifierETA-C-012675
Rosa Californica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012676
Rosa canina CA-NHPEU-NOVEL Not yet graded
Rosa Canina Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012678
Rosa Canina Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012679
Rosa Canina Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012680
Rosa Canina Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-012681
Rosa canina-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012682
Rosa centifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012683